Cumulative Investment of 52 Billion KRW... Service Diversification

Dr. Now.

Dr. Now.

View original image


[Asia Economy Reporter Lee Gwan-joo] Remote medical platform Doctor Now announced on the 2nd that it has completed a Series B investment round worth 40 billion KRW. In this round, Doctor Now's corporate valuation was assessed at over 200 billion KRW, and the total accumulated investment to date is 52 billion KRW.


The Series B round included participation from many existing investors such as SoftBank Ventures, Saehan Startup Investment, Hashed, Crit Ventures, Primer Saje, and Mirae Asset Capital, as well as new venture capital firms including N Partners, Goodwater Capital, SmartStudy Ventures, and Spring Ventures.


Through this investment, Doctor Now plans to focus on diversifying its services across the entire healthcare spectrum, from prevention of various diseases to health management, based on its core medical sectors of non-face-to-face consultations and prescription medications. Additionally, it aims to lower the medical barriers and increase accessibility while providing users with more convenient medical services and expanding the digital base so that users can more easily experience medical benefits.


Jang Ji-ho, CEO of Doctor Now, said, "We are fully committed as one team solely for the benefit and satisfaction of our users. Thanks to the investors who resonated with our efforts and direction, we were able to complete the Series B round." He added, "We plan to build a structure that allows us to gather talent focused on growth and to grow through faster execution and learning from trial and error."



Since launching its service in December 2020, Doctor Now has recorded 5.6 million cumulative app users and 3 million cumulative app downloads. Collaborating with over 1,500 affiliated medical institutions centered around neighborhood clinics and pharmacies, it provides medical services such as remote consultations and prescription drug delivery across various medical departments including internal medicine, family medicine, pediatrics, and dermatology.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing